Future Diagnostics Solutions offers IVD (immuno) Assay Development and Contract Manufacturing Services to IVD multinationals, mid-sized biotech and small startup companies within the global medical diagnostic market and device industry.
Founded in 1999, Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Streamline reputation management: Aggregate reviews from multiple platforms and engage customers with our seamless reply feature, enhancing your brand's trust!